Journal
CURRENT PSYCHIATRY REPORTS
Volume 20, Issue 2, Pages -Publisher
SPRINGER
DOI: 10.1007/s11920-018-0873-3
Keywords
GWAS; Omics; Brain; Nicotine/smoking; Alcohol; Drugs
Categories
Funding
- NIDA [R01s DA035825, DA042090, R01 DA036583]
- NATIONAL INSTITUTE ON DRUG ABUSE [R01DA035825, R01DA042090, R01DA036583] Funding Source: NIH RePORTER
Ask authors/readers for more resources
Purpose of Review With the advent of the genome-wide association study (GWAS), our understanding of the genetics of addiction has made significant strides forward. Here, we summarize genetic loci containing variants identified at genome-wide statistical significance (P < 5 x 10(-8)) and independently replicated, review evidence of functional or regulatory effects for GWAS-identified variants, and outline multi-omics approaches to enhance discovery and characterize addiction loci. Recent Findings Replicable GWAS findings span 11 genetic loci for smoking, eight loci for alcohol, and two loci for illicit drugs combined and include missense functional variants and noncoding variants with regulatory effects in human brain tissues traditionally viewed as addiction-relevant (e.g., prefrontal cortex [PFC]) and, more recently, tissues often overlooked (e.g., cerebellum). Summary GWAS analyses have discovered several novel, replicable variants contributing to addiction. Using larger sample sizes from harmonized datasets and new approaches to integrate GWAS with multiple 'omics data across human brain tissues holds great promise to significantly advance our understanding of the biology underlying addiction.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available